by Collectif | 28 Nov, 2017 | Bioethics press synthesis | Genome
In California, the first patient has been treated by editing his own gene in order to correct a gene permanently in his liver cells. Brian Madeux, aged 44, is suffering from a single-gene disease, namely Hunter syndrome[1]. On Monday, he received billions of...
by Collectif | 28 Nov, 2017 | Bioethics press synthesis | Embryo research and alternatives
The results of two clinical trials using human embryonic stem cells to treat AMD [1] have just been presented at the annual meeting of the American Academy of Ophthalmology. The cells injected into patients’ eyes “appear to have replaced cells damaged...
by Collectif | 28 Nov, 2017 | Bioethics press synthesis | Embryo research and alternatives
Jean-François Bouvet, Doctor of Sciences and author of Bébés à la carte (designer babies), has just published an article in Le Point in which he highlights the “trivialisation of genetically modified embryos”. The first experiment of this type,...
by Collectif | 28 Nov, 2017 | Bioethics press synthesis | End of life
Switzerland is recording a considerable rise in assisted suicides: 965 individuals “took a lethal substance” in 2015 compared to 742 in 2014 and 86 in 2000. These figures only take into consideration those “individuals living” in the country...
by Collectif | 28 Nov, 2017 | Bioethics press synthesis | End of life
Freezing a living person is tantamount to murder but a Russian company, KrioRus[1], is fund-raising to build its laboratory in Switzerland. It aims to offer people, who want to die, a chance to be frozen by circumventing assisted suicide legislation. According...